Bristol-Myers Squibb Co (NYSE: BMY)

DRUGS - Drug Manufacturers - Major
Sector: Health Care

Stock price data as of 12/01/2023

Closing price: 50.10

Support price level:	N/A
Resistance price level:	$53.63
Relative strength index (14-day RSI)	47.1
Beta	0.32

With a -37.6 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
The price of this low-beta stock is expected to increase by 0.32% for every 1% increase in the S&P-500.
Volatility is forecast to fall over the next month.
Price broke below prior support level - a short-term bearish signal.

Low	High	Price as % of Range
$48.48	$81.13	6.4%

200 day	50 day	20 day	10 day
$62.38	$53.76	$50.40	$49.35

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
23.4%	29.1%	25.2%	24.1%

There is an estimated 5% probability that the stock price of Bristol-Myers Squibb Co will fall by more than: